Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

RaySearch Laboratories AB (publ)

27R
Current price
20.35 EUR +0.51 EUR (+2.57%)
Last closed 231.00 SEK
ISIN SE0000135485
Sector Healthcare
Industry Health Information Services
Exchange Frankfurt Exchange
Capitalization 7 932 975 147 SEK
Yield for 12 month +156.95 %
1Y
3Y
5Y
10Y
15Y
27R
21.11.2021 - 28.11.2021

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) is headquartered in Stockholm, Sweden. Address: EugeniavAegen 18C, Stockholm, Sweden, 113 68

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2 908.25 SEK

P/E ratio

45.40

Dividend Yield

0.31 %

Current Year

+1 019 507 144 SEK

Last Year

+841 459 263 SEK

Current Quarter

+292 542 060 SEK

Last Quarter

+318 037 744 SEK

Current Year

+913 205 650 SEK

Last Year

+746 714 709 SEK

Current Quarter

+264 758 329 SEK

Last Quarter

+294 357 347 SEK

Key Figures 27R

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 247 153 128 SEK
Operating Margin TTM 24.88 %
PE Ratio 45.40
Return On Assets TTM 6.48 %
PEG Ratio
Return On Equity TTM 20.76 %
Wall Street Target Price 2 908.25 SEK
Revenue TTM 1 125 655 976 SEK
Book Value 21.39 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 33.20 %
Dividend Yield 0.31 %
Gross Profit TTM 1 018 455 904 SEK
Earnings per share 5.10 SEK
Diluted Eps TTM 5.10 SEK
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 462.10 %
Profit Margin 13.40 %

Dividend Analytics 27R

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

1 year

5Y Average Payout Ratio

35.00 %

Dividend History 27R

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.70
Ex Dividend Date 23.05.2024
Forward Annual Dividend Yield 0.35 %
Last Split Factor 3:1
Payout Ratio 13.72 %
Last Split Date 25.06.2008
Dividend Date

Stock Valuation 27R

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 45.40
Forward PE 31.15
Enterprise Value Revenue 6.82
Price Sales TTM 7.05
Enterprise Value EBITDA 28.29
Price Book MRQ 7.39

Financials 27R

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 27R

For 52 weeks

83.13 SEK 235.39 SEK
50 Day MA 203.12 SEK
Shares Short Prior Month
200 Day MA 157.17 SEK
Short Ratio
Shares Short
Short Percent